aspirin 81 mg daily as prophylaxis in all patients at high risk for preeclampsia Because active disease affects maternal and pregnancy outcome, we strongly suggest, as good practice, monitoring SLE disease activity with clinical history, examination, and laboratory tests at least once per trimester. Abnormalities in the complete blood cell count, differential cell count, urinalysis results and urinary protein:creatinine ratio, or anti-DNA, C3, or C4 levels may indicate possible SLE flare and/or